The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of Auxilium Pharmaceuticals, Inc. (“Auxilium” or the
“Company”) (Nasdaq: AUXL) relating to the proposed buyout of the Company
by Endo International plc (“Endo”).
On October 9, 2014, Auxilium and Endo announced the signing of a
definitive agreement pursuant to which Endo will acquire Auxilium in a
transaction valued at approximately $2.6 billion.
for - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks